Professor, Neurology, Perelman School of Medicine
Neurology
Dr. Murray Grossman, MD
|
|
Give Review
Dr. Murray Grossman is an expert in the field of Neurology. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Elected Member". Murray Grossman is a published doctor. He published 75 publications, including: 'Cognitive and anatomic double dissociation in the representation of concrete and abstract words in semantic variant and behavioral variant frontotemporal degeneration.' Murray Grossman accepts Medicare.
Publications
- Cognitive and anatomic double dissociation in the representation of concrete and abstract words in semantic variant and behavioral variant frontotemporal degeneration.
- Semantics of the Visual Environment Encoded in Parahippocampal Cortex.
- Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.
- Deep Clinical and Neuropathological Phenotyping of Pick's Disease.
- Semi-Automated Digital Image Analysis of Pick's Disease and TDP-43 Proteinopathy.
- How the Brain learns how few are "many": An fMRI study of the flexibility of quantifier semantics.
- Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
- Defects of mutant DNMT1 are linked to a spectrum of neurological Disorders.
- Getting on the same page: The neural basis for social coordination deficits in behavioral variant frontotemporal degeneration.
- Exome sequencing in amyotrophic lateral Sclerosis identifies risk genes and pathways.
- C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence.
- Impaired Cognitive Flexibility in Amyotrophic Lateral Sclerosis.
- White matter Disease contributes to apathy and disinhibition in behavioral variant frontotemporal dementia.
- Optimal Symmetric Multimodal Templates and Concatenated Random Forests for Supervised Brain Tumor Segmentation (Simplified) with ANTsR.
- Hypermethylation of repeat expanded C9orf72 is a clinical and molecular Disease modifier.
- ALS-Plus Syndrome: Non-pyramidal features in a large ALS cohort.
- Counting or chunking? Mathematical and heuristic abilities in patients with corticobasal Syndrome and posterior cortical atrophy.
- Corticobasal Syndrome: Five new things.
- A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.
- Davunetide in patients with progressive supranuclear Palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
- Frontotemporal Dementia and its subtypes: a genome-wide association study.
- Relating Brain anatomy and cognitive ability using a multivariate multimodal framework.
- Action verb comprehension in amyotrophic lateral sclerosis and Parkinson's Disease.
- The power of neuroimaging biomarkers for screening frontotemporal Dementia.
- Qualification of a Surrogate Matrix-Based Absolute Quantification Method for Amyloid-β42 in Human Cerebrospinal Fluid Using 2D UPLC-Tandem Mass Spectrometry.
- Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal Dementia (bvFTD).
- TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
- Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis.
- Frontotemporal neural systems supporting semantic processing in Alzheimer's Disease.
- Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.
- Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population.
- Grammatical comprehension deficits in non-fluent/agrammatic primary Progressive aphasia.
- Development and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration.
- Comparative semantic profiles in semantic dementia and Alzheimer's Disease.
- Acetylated tau neuropathology in sporadic and hereditary tauopathies.
- Differentiating primary Progressive aphasias in a brief sample of connected speech.
- Contribution of cerebrovascular Disease in autopsy confirmed neurodegenerative Disease cases in the National Alzheimer's Coordinating Centre.
- Stages of pTDP-43 pathology in amyotrophic lateral Sclerosis.
- Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration.
- Impairment of script comprehension in Lewy body spectrum Disorders.
- Behavior matters-cognitive predictors of survival in amyotrophic lateral Sclerosis.
- White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.
- The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier).
- Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's Disease.
- Self-appraisal in behavioural variant frontotemporal degeneration.
- Eigenanatomy improves detection power for longitudinal cortical change.
- Whole-Brain Analysis of Amyotrophic Lateral Sclerosis by Using Echo-Planar Spectroscopic Imaging.
- Heteromodal conceptual processing in the angular gyrus.
- Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease.
- Can MRI screen for CSF biomarkers in neurodegenerative Disease?
- Category-specific semantic memory: Converging evidence from bold fMRI and alzheimer's Disease.
- Disruption of large-scale neural networks in non-fluent/agrammatic variant primary Progressive aphasia associated with frontotemporal degeneration pathology.
- Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral Sclerosis.
- The neural basis for establishing a focal point in pure coordination games.
- FTD/ALS families are no longer orphaned: The C9ORF72 story.
- Plasma multianalyte profiling in mild cognitive impairment and Alzheimer Disease.
- Frontal lobe abNormalities on MRS correlate with poor letter fluency in ALS.
- Gray matter density of auditory association cortex relates to knowledge of sound concepts in primary Progressive aphasia.
- The non-fluent/agrammatic variant of primary Progressive aphasia.
- White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration.
- CSF biomarkers cutoffs: the importance of coincident neuropathological Diseases.
- Multimodal Comparative Studies of Neurodegenerative Diseases.
- Comparison of cerebrospinal fluid levels of tau and aβ 1-42 in Alzheimer Disease and frontotemporal degeneration using 2 analytical platforms.
- fMRI evidence for strategic decision-making during resolution of pronoun reference.
- Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
- Plasma biomarkers of depressive symptoms in older adults.
- Registration based cortical thickness measurement.
- A high-resolution computational atlas of the human hippocampus from postmortem magnetic resonance imaging at 9.4 T.
- Deep Brain stimulation in the treatment of obesity.
- Impaired action knowledge in amyotrophic lateral Sclerosis.
- Processing ambiguity in a linguistic context: decision-making difficulties in non-aphasic patients with behavioral variant frontotemporal degeneration.
- Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and Diseased human brain.
- Age-related vulnerability in the neural systems supporting semantic processing.
- Converging evidence for the processing costs associated with ambiguous quantifier comprehension.
Schools
McGill University Faculty Of Medicine
Royal Victoria Hospital McGill
Hospital Of The University Of Pennsylvania
Aphasia Rsch Center Boston University
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Nerve Block, Somatic
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
University of Pennsylvania Health System -
McGill University Faculty of Medicine
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1790717932 | |
| NPPES Provider LastName | GROSSMAN | |
| NPPES Provider FirstName | MURRAY | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Neurology | |
| Total Claim Count | 732.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790717932 |
| Last Name Of The Provider | GROSSMAN |
| First Name Of The Provider | MURRAY |
| View All |
Similar Doctors
|
|
Dr. Krista M. Lim-Hing, MD |
|
|
Dr. Matthew A. Berk, MD |
|
|
Dr. Amit Sachdev, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neerali S. Bernard, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Orthmann Murphy, MD |
|
|
Dr. Adeniyi Fisayo, MD |
|
|
Dr. Laura J. Balcer, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Lori A. Sheehan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seema Nair, MD |
|
|
Dr. Rajiv Narula, MD |
|
|
Dr. Amy Y. Tsou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chandril Chugh, MD |
|
|
Dr. Ana Recober-Montilla, MD
This Doctor is OpenDoctor Recommended.
|